-
Cannabinoid Treatment Significantly Reduces Fibromyalgia Pain And Improves Quality Of Life, New Tilray-Backed Study Finds
Monday, September 9, 2024 - 9:50am | 528Read More...Tilray Medical, a division of Canadian cannabis giant Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) announced on Monday a new scientific publication supported by Tilray Medical titled, Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms: A Case Series (TOMAS). The study,...
-
90% Of Medical Marijuana Patients Over 50 Are Treating Chronic Pain And Arthritis, Finds New Tilray Study
Tuesday, July 9, 2024 - 9:34am | 531Read More...Tilray Medical, a division of Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) released its new scientific publication on Tuesday titled, “Medical Cannabis for Patients Over Age 50: A Multi-Site, Prospective Study of Patterns of Use and Health Outcomes.“ The new research builds on a...
